nasdaq

Biotech firms switch listings from Nasdaq to HKEX

Hong Kong-listed biotech firms are outperforming as Trump’s policies cause firms to change course from their traditional US destination, with more HKEX listings expected in the second half of 2025; experts shared their views at BIOHK.
September 23, 2025

Chinese lidar maker Hesai Technology lists on HKEX

Cornerstone investors in the tech firm's listing include Hillhouse Investment Management, Taikang Life Insurance and Grab; net proceeds were $514m and the firm's valuation climbed above $4.6bn on its September 16 debut.
September 16, 2025

Exclusive interview with SGX on NYSE tie-up

FinanceAsia talks to SGX head of global sales and origination, Pol de Win, on the exchange’s efforts to become a venue of choice when global markets recover.
August 02, 2022

YY returns with $400 million CB

Nasdaq-listed Chinese internet firm bounces back from failed November CB after posting solid results for 2013.
March 19, 2014